News

Get lifetime access to PDF Agile for Windows for only $39.99 and handle editing, converting, and securing PDFs like a pro.
PMV Pharmaceuticals has reported a 43% response rate in a midphase ovarian cancer trial, putting the biotech on a track it believes will lead to a filing for FDA approval in the first quarter of 2027.